Exosome-Based Therapies for Skin Aging: Sources, Mechanisms, and Evidence from Preclinical and Clinical Studies.
- 1Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Abstract
Skin aging is an inevitable physiological process co-driven by endogenous genetic programs and exogenous environmental factors, characterized by the progressive deterioration of skin structure and function, which manifests as wrinkles, sagging, pigmentation, and impaired barrier function. Extracellular vesicles, particularly exosomes, are nanoscale membranous vesicles actively secreted by cells, functioning as pivotal mediators of intercellular communication through the transport of diverse bioactive molecules. Exosomes derived from diverse sources, including mesenchymal stem cells, somatic cells, plants, milk, and plasma, can effectively reverse skin aging through multiple mechanisms, such as alleviating oxidative damage, promoting collagen synthesis, inhibiting excessive expression of matrix metalloproteinases (MMPs), clearing senescent cells, and improving mitochondrial function. Additionally, engineering modifications and optimized delivery systems can further enhance the targeting ability and synergistic therapeutic efficacy of exosomes. However, the clinical application of exosomes remains constrained by exosome heterogeneity, the lack of standardized isolation and production methods, limited delivery efficiency, and insufficient long-term clinical evidence regarding safety and efficacy. This review systematically summarizes the fundamental research, mechanisms, and clinical evidence of exosomes in combating skin aging. We comprehensively explore the application prospects and challenges, emphasizing the significant values of different exosomes in combating skin aging.
Related
- Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications
- Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads
- Ginsenoside Rg1 for ischemic heart disease injury: preclinical evidence and possible mechanisms
- β-Ionone for Cancer Therapy: Molecular Mechanisms, Apoptotic Signaling, Preclinical Evidence, and Translational Perspectives
- VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities
BibTeX
@article{zhang2026exosomebased,
title = {{Exosome-Based Therapies for Skin Aging: Sources, Mechanisms, and Evidence from Preclinical and Clinical Studies.}},
author = {Boyu Zhang and Xinrong Xue and Yiping Wu and Qi Zhang and Min Wu},
journal = {International journal of nanomedicine},
year = {2026},
month = oct,
doi = {10.2147/ijn.s648176},
url = {https://europepmc.org/article/MED/42910213},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Exosome-Based Therapies for Skin Aging: Sources, Mechanisms, and Evidence from Preclinical and Clinical Studies.
AU - Boyu Zhang
AU - Xinrong Xue
AU - Yiping Wu
AU - Qi Zhang
AU - Min Wu
PY - 2026
DA - 2026/10/17
JO - International journal of nanomedicine
DO - 10.2147/ijn.s648176
UR - https://europepmc.org/article/MED/42910213
AB - Skin aging is an inevitable physiological process co-driven by endogenous genetic programs and exogenous environmental factors, characterized by the progressive deterioration of skin structure and function, which manifests as wrinkles, sagging, pigmentation, and impaired barrier function. Extracellular vesicles, particularly exosomes, are nanoscale membranous vesicles actively secreted by cells, functioning as pivotal mediators of intercellular communication through the transport of diverse bioactive molecules. Exosomes derived from diverse sources, including mesenchymal stem cells, somatic cells, plants, milk, and plasma, can effectively reverse skin aging through multiple mechanisms, such as alleviating oxidative damage, promoting collagen synthesis, inhibiting excessive expression of matrix metalloproteinases (MMPs), clearing senescent cells, and improving mitochondrial function. Additionally, engineering modifications and optimized delivery systems can further enhance the targeting ability and synergistic therapeutic efficacy of exosomes. However, the clinical application of exosomes remains constrained by exosome heterogeneity, the lack of standardized isolation and production methods, limited delivery efficiency, and insufficient long-term clinical evidence regarding safety and efficacy. This review systematically summarizes the fundamental research, mechanisms, and clinical evidence of exosomes in combating skin aging. We comprehensively explore the application prospects and challenges, emphasizing the significant values of different exosomes in combating skin aging.
SN - 1176-9114
SN - 1178-2013
ER -